Alcon AG (ALC)
80.21
+1.54
(+1.96%)
USD |
NYSE |
Dec 10, 16:00
80.24
+0.02
(+0.03%)
Pre-Market: 20:00
Alcon EPS Diluted (Quarterly): 0.4779 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| STAAR Surgical Co. | 0.1758 |
| Boston Scientific Corp. | 0.5048 |
| Novartis AG | 2.020 |
| Solventum Corp. | 7.218 |
| ADC Therapeutics SA | -0.3002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 237.00M |
| Revenue (Quarterly) | 2.614B |
| Total Expenses (Quarterly) | 2.377B |
| Enterprise Value | 43.14B |
| Gross Profit Margin (Quarterly) | 55.78% |
| Profit Margin (Quarterly) | 9.07% |
| Earnings Yield | 2.62% |
| Operating Earnings Yield | 3.75% |
| Normalized Earnings Yield | 2.780 |